In simple terms, detailed informations from Phase I IV surveys on therapeutic regions for advanced psychoanalysis and meta-analysis.
The basic idea is that 300K+ Demographic surveys, rating touchstones, dosage, safety and standardized publication tie-ins for inter-study analysis and calibration.
Every trial outcome, analytically accessible.
See Library DocumentationHR, OR, p-values, confidence intervals extracted.
The approach is to the harmonised definitions of evaluation criteria by presenters and forms allow for benchmarking of performance and meta-analytic success rates.
Explore Efficacy DataMedDRA coded, exposure-adjusted incidence rates.
We should consider that the standardized refuge analysis in the surveys shows course effects, dose-response relationships, and patient risk stratification.
View Safety DatasetsAge, gender, genetics, comorbidity effects modeled.
Most researchers agree that rich covariant data backing precision medication and test plan optimisation for succeeding studies.